Lunai Bioworks Inc. (LNAI)
OTCMKTS · Delayed Price · Currency is USD
0.1648
-0.0713 (-30.20%)
At close: Oct 29, 2026

Lunai Bioworks Financials Overview

Millions USD. Fiscal year is Jul - Jun.

Revenue & Profits

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Revenue
0.050.05----
Revenue Growth
------
Gross Profit
0.050.05----
Operating Income
-7.87-7.87-18.55-27.39-19.6-22.83
Net Income
-3.56-3.56-178.01-88.43-39.68-113.43
Earnings Per Share
-1.06-1.06-86.27-72.55-56.42-172.76
EPS Growth
------

Cash & Debt

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Cash & Investments
1.711.710.480.221.879.17
Total Debt
1.491.4910.173.795.787.02
Net Cash (Debt)
0.220.22-9.69-3.57-3.92.16
Net Cash Growth
------83.86%
Net Cash Per Share
0.070.07-4.70-2.93-5.553.28

Cash Flow & CapEx

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Operating Cash Flow
-5.29-5.29-7.87-10.97-11.77-15.73
Capital Expenditures
-0-0--0.07-0.03-0.01
Free Cash Flow
-5.29-5.29-7.87-11.04-11.8-15.74
Free Cash Flow Growth
------

Margins

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Gross Margin
100.00%100.00%----
Operating Margin
-15129.28%-15129.28%----
Pretax Margin
-6851.98%-6851.98%----
Profit Margin
-6851.98%-6851.98%----
FCF Margin
-10173.56%-10173.56%----

Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingNov '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
PS Ratio
15.96285.16----